Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | EAI045 |
Synonyms | |
Therapy Description |
EAI045 is a 4th generation, allosteric, non-ATP competitive inhibitor of epidermal growth factor receptor (EGFR) with selective activity against EGFR L858R/T790M and C797S, which when combined with anti-EGFR antibodies may lead to growth inhibition in tumors harboring EGFR T790M or C797S (PMID: 27251290, PMID: 27840244, PMID: 32666476). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EAI045 | EAI-045|EAI 045 | EGFR Inhibitor 4th gen 16 | EAI045 is a 4th generation, allosteric, non-ATP competitive inhibitor of epidermal growth factor receptor (EGFR) with selective activity against EGFR L858R/T790M and C797S, which when combined with anti-EGFR antibodies may lead to growth inhibition in tumors harboring EGFR T790M or C797S (PMID: 27251290, PMID: 27840244, PMID: 32666476). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|